Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS SE & CO. KGAA

(FRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Fresenius SE & Co. KGaA: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

05/31/2021 | 07:35am EDT

DGAP Total Voting Rights Announcement: Fresenius SE & Co. KGaA / Total Voting Rights Announcement
Fresenius SE & Co. KGaA: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

31.05.2021 / 13:33
Total Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Publication of total number of voting rights

1. Details of issuer
Fresenius SE & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg v.d.H.
Germany

2. Type of capital measure
  Type of capital measure Date of status / date of effect
X Conditional capital increase (Sec. 41 para. 2 WpHG) 31.05.2021
  Other capital measure (Sec. 41 para. 1 WpHG)

3. New total number of voting rights:
557716248



31.05.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Fresenius SE & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg v.d.H.
Germany
Internet: www.fresenius.com

 
End of News DGAP News Service

1202675  31.05.2021 

fncls.ssp?fn=show_t_gif&application_id=1202675&application_name=news&site_id=zonebourse_sftp

© EQS 2021
All news about FRESENIUS SE & CO. KGAA
07/23FMC FRESENIUS MEDICAL CARE AG & CO K : Jefferies gives a Sell rating
MD
07/23FRESENIUS SE : Jefferies reiterates its Sell rating
MD
07/21FMC FRESENIUS MEDICAL CARE AG & CO K : Goldman Sachs maintains a Buy rating
MD
07/21FRESENIUS SE : JP Morgan maintains a Buy rating
MD
07/20FMC FRESENIUS MEDICAL CARE AG & CO K : JP Morgan gives a Neutral rating
MD
07/20FRESENIUS SE : Berenberg remains its Buy rating
MD
07/20FMC FRESENIUS MEDICAL CARE AG & CO K : Receives a Buy rating from Berenberg
MD
07/14FRESENIUS MEDICAL CARE : Truist Securities Adjusts Fresenius Medical Care PT to ..
MT
07/14FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Neutral rating from Morgan Stanley
MD
07/14FRESENIUS SE : Morgan Stanley maintains a Buy rating
MD
More news
Financials
Sales 2021 37 017 M 43 562 M 43 562 M
Net income 2021 1 791 M 2 108 M 2 108 M
Net Debt 2021 22 155 M 26 072 M 26 072 M
P/E ratio 2021 14,2x
Yield 2021 1,87%
Capitalization 25 521 M 30 022 M 30 034 M
EV / Sales 2021 1,29x
EV / Sales 2022 1,18x
Nbr of Employees 310 842
Free-Float 73,1%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 45,78 €
Average target price 48,52 €
Spread / Average Target 6,00%
EPS Revisions
Managers and Directors
Stephan Sturm President & Chief Executive Officer
Rachel Clare Empey Chief Financial Officer
Wolfgang Kirsch Chairman-Supervisory Board
Sebastian Biedenkopf Legal, Compliance & Human Resources Director
Klaus-Peter Müller Independent Member-Supervisory Board
Sector and Competitors